Linshom Medical awarded a $3.5M SBIR grant
BALTIMORE, MD, UNITED STATES, November 5, 2026 /EINPresswire.com/ -- Linshom Medical was awarded a $3.5M SBIR Phase 2B
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
BALTIMORE, MD, UNITED STATES, November 5, 2026 /EINPresswire.com/ — Linshom Medical was awarded a $3.5M SBIR Phase 2B grant from the National Institutes of Health (NIH), National Heart Lung and Blood Institute (NHLBI).
“This award initially funds engineering efforts to de-tether the patient from the bedside monitor via wireless capability, enabling portable continuous respiratory monitoring”, said Ronen Feldman, Principal Investigator and CTO. “This award further validates Linshom Medical’s technology for critical bedside respiratory monitoring. The grant then supports a multi-center clinical trial to quantify the medical-economic benefits of early detection and early intervention of patient respiratory decline”.
The developments funded by this grant will enable respiratory monitoring to travel with the patient wherever they are in their health care journey. Evaluation and scoring systems don’t work well for identifying patients who will have respiratory trouble after surgery. At risk patients need simple, affordable continuous respiratory monitoring for assured safe and effective outcomes.
“The systems and technology in place today respond to respiratory decline after it occurs”, according to Richard Hughen, CEO. “A previous study at Ohio State Wexner Medical Center (OSU) proved the early detection capability of the Linshom Medical sensor, providing health care providers time to intervene before a crisis develops. Now, with the new clinical trial, we aim to quantify the medical-economic benefits of early detection and early intervention”.
More information on the NIH award can be found at:
https://reporter.nih.gov/search/_23YjKFdJEWqDILEQZsPTg/project-details/10546880
About Linshom Medical, Inc.
Linshom Medical is first to deliver an Operating Room quality respiratory profile to the patient bedside for continuous, predictive respiratory monitoring (CPRM). Our patented and FDA cleared sensor provides a predictive (vs. responsive) respiratory profile including Respiratory Rate (RR), relative Tidal Volume (rVt) and Seconds Since Last Breath (SSLB) that are all delivered continuously and in real time. Our mission is to eliminate the morbidity, mortality and cost due to unrecognized respiratory compromise in healthcare.
Linshom is currently raising a Series A Preferred round of investment. For more information, visit www.LinshomMedical.com or write to info@LinshomMedical.com.
Richard Hughen
Linshom Medical, Inc.
rhughen@LinshomMedical.com
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
